Biora Therapeutics (STU:4ZU0) EV-to-Revenue : 105.14 (As of May. 30, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biora Therapeutics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biora Therapeutics's enterprise value is €52.67 Mil. Biora Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €0.50 Mil. Therefore, Biora Therapeutics's EV-to-Revenue for today is 105.14.

The historical rank and industry rank for Biora Therapeutics's EV-to-Revenue or its related term are showing as below:

STU:4ZU0' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.47 Med: 274.05 Max: 6065.97
Current: 105.16

During the past 6 years, the highest EV-to-Revenue of Biora Therapeutics was 6065.97. The lowest was 0.47. And the median was 274.05.

STU:4ZU0's EV-to-Revenue is ranked worse than
83.95% of 1034 companies
in the Biotechnology industry
Industry Median: 7.98 vs STU:4ZU0: 105.16

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Biora Therapeutics's stock price is €0.535. Biora Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.02. Therefore, Biora Therapeutics's PS Ratio for today is 31.47.

Biora Therapeutics EV-to-Revenue Historical Data

The historical data trend for Biora Therapeutics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biora Therapeutics EV-to-Revenue Chart

Biora Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2,250.71

335.30

420.38

17,448.94

Biora Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															663.96	1,589.01	6,701.33	17,448.94	127.59

Competitive Comparison of Biora Therapeutics's EV-to-Revenue

For the Biotechnology subindustry, Biora Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biora Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biora Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biora Therapeutics's EV-to-Revenue falls into.

Biora Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biora Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	52.674	/	0.501
	=	105.14

Biora Therapeutics's current Enterprise Value is €52.67 Mil.
Biora Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.50 Mil.

Biora Therapeutics (STU:4ZU0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biora Therapeutics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.535	/	0.017
	=	31.47

Biora Therapeutics's share price for today is €0.535.
Biora Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02.

Biora Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biora Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biora Therapeutics (STU:4ZU0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (STU:4ZU0) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BIOR:USA

Address

4330 La Jolla Village Drive, Suite 300, San Diego, CA, USA, 92122

Website

https://www.bioratherapeutics.com

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States.

Biora Therapeutics (STU:4ZU0) Headlines

No Headlines